-transparent.png){kind=logo}
Twenty-seven evaluable patients with advanced malignant melanoma received fludarabine phosphate in a daily x 5 injection. Initial dosing was based on the presence of previous radiation therapy. There was no response seen in these patients despite appropriate dose escalation. Myelosuppression occurred without significant sequelae.
Related Publications
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
April 1988,
Investigational new drugs,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
May 1987,
Cancer treatment reports,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
January 1993,
Investigational new drugs,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
October 1987,
Cancer treatment reports,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
May 1990,
Investigational new drugs,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
January 1995,
Investigational new drugs,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
January 1987,
Investigational new drugs,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
April 1984,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
July 1978,
Cancer treatment reports,
J A Kish, and
K Kopecky, and
M K Samson, and
D D Von Hoff, and
W S Fletcher, and
R A Kempf, and
F M Muggia
November 1987,
Cancer treatment reports,
